Rajabian M, Heidarzadeh A, Hosseini F, Akbari A, Ahmadinia H, Raeaszadeh M. Impact of Hemp Seed Consumption on the General Health of Older Adults: A Controlled Clinical Trial. , Salmand: Iranian Journal of Ageing. 2026; 21 (3) :380-391
URL:
http://salmandj.uswr.ac.ir/article-1-3169-en.html
1- Department of Geriatric Nursing, Geriatric Care Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
2- Department of Medical Surgical Nursing, Geriatric Care Research Center, School of Nursing and Midwifery, Rafsanjan University of Medical Science s, Rafsanjan, Iran.
3- Department of Community Health Nursing, Geriatric Care Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. , Hisseubuf1317@gmail.com
4- Department of Medical Surgical Nursing, Social Determinants of Health Research Center, School of Nursing and Midwifery, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
5- Department of Epidemiology and Biostatistics, Occupational Environment Research Center, School of Health, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
6- Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran .
Abstract: (2455 Views)
Objectives One major global challenge is improving the general health of older adults. This study aimed to investigate the impact of cannabis use on the general health of older adults.
Methods & Materials This randomized, triple-blind controlled trial included 70 older adults randomly assigned to intervention and control groups. The intervention group consumed 700 mg oral capsules of Hemp Seed extract three times a day for 4 weeks, while the control group received cornstarch capsules as a placebo. Both groups completed the 28-item general health questionnaire (GHQ-28) before, immediately after, and one month post-intervention. Data analysis was conducted in SPSS software, version 22 using descriptive and inferential statistics.
Results Out of the 70 participants, 65 completed the questionnaires (44.6% male and 55.3% female). Their mean age was 67.09±2.66 years in the intervention group and 66.63±2.72 years in the control group. Before the intervention, the two groups had no statistically significant difference in mean total GHQ-28 score (P=0.758). However, immediately after the intervention, a significant difference between groups was observed (P<0.001). The intervention group showed significantly higher scores at all three time points (P<0.001), while the control group did not show a significant difference (P=0.291).
Conclusion The intervention group showed significantly higher scores at all three time points (P<0.001), while the control group did not show a significant difference (P=0.291). Significant reductions were observed in somatic symptoms and anxiety/insomnia in the intervention group (P<0.001), with a significant between-group difference at post-test and follow-up.
Type of Study:
Research |
Subject:
Psychiatry Received: 2025/11/14 | Accepted: 2026/04/21 | Published: 2026/10/02